CBR-5884 is an selective, active of phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 33 µM. CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with high serine biosynthetic activity. CBR-5884 selectively inhibits the proliferation of melanoma and breast cancer lines that have a high propensity for serine synthesis. Biochemical characterization of the inhibitor revealed that it was a noncompetitive inhibitor that showed a time-dependent onset of inhibition and disrupted the oligomerization state of PHGDH
Molecular Weight:
336.39
Purity:
99.97%
CAS Number:
[681159-27-3]
Formula:
C14H12N2O4S2
Target:
Dehydrogenase
T14884
* VAT and and shipping costs not included. Errors and price changes excepted
